Clopidogrel Response in Acute Ischemic Stroke "Bo-CRISP"


Phase N/A Results N/A

Trial Description

The aim of this study was to determine the prevalence rate and risk factors for chemical laboratory clopidogrel low-response (CLR) in the acute phase after an ischemic stroke.


Trial Design

  • Observation: Case-Only
  • Perspective: Prospective
  • Sampling: Non-Probability Sample

Trial Population

Patients with an acute ischemic stroke admitted to our hospital and treated with clopidogrel


Type Measure Time Frame Safety Issue
Primary Result of platelet function test 1 day No